IPSEY:OTCMKTS
Ipsen ADR Rep 1/4 Ord Shs
$44.75
arrow_downward
-3.20%(-1.48) 1D
Sep 17, 4:00:00 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for IPSEY...
Open
$44.82
High
$44.82
Low
$44.75
Mkt. cap
13.16B
Avg. vol.
524.00
Volume
266.00
52-wk high
$51.10
52-wk low
$32.02
Beta
0.41
Shares outstanding
335.26M
No. of employees
6K
Open
$44.82
High
$44.82
Low
$44.75
Mkt. cap
13.16B
Avg. vol.
524.00
Volume
266.00
52-wk high
$51.10
52-wk low
$32.02
Beta
0.41
Shares outstanding
335.26M
No. of employees
6K
News stories
From web sources and news partners
TipRanks
·
3 hours ago
Ipsen Adds Veteran Life Sciences Executive Mariette Finet to Its Board
Investing.com
·
4 hours ago
Ipsen appoints Mariette Finet to board of directors
Yahoo Finance
·
4 hours ago
Ipsen appoints Mariette Finet to its Board of Directors
Stock Titan
·
4 hours ago
More than 35 years in healthcare: Ipsen adds a board director
Profile
Ipsen is a French biopharmaceutical company headquartered in Paris, France, with a focus on drug development and commercialization in three therapeutic areas: oncology, rare diseases and neuroscience. Ipsen is one of the world's top 15 biopharmaceutical companies in terms of oncology sales.
Ipsen, founded by Henri Beaufour in 1929, has approximately 5000 employees worldwide. Ipsen's medicines are registered in 88 countries with direct commercial presence in over 30 countries. Ipsen has 4 global R&D hubs and 3 pharmaceutical development centers around the world. Ipsen has been a family-owned business for the past 90 years and is publicly traded on the Euronext Paris as part of the SBF 120 index. The Beaufour family owns 57% of its shares and 73% of its voting rights, and two of its members, Anne Beaufour and Henri Beaufour, sit on its board of directors. Wikipedia
About Ipsen ADR Rep 1/4 Ord Shs